Health · 4 views

Bid to Block GLP-1 Ads Denied; First Weekly Insulin for T2D in Kids; Fertility Fell

Source Summary Published 1h 42m ago Brief Under 1 min brief

Story intelligence

Coverage Single outlet Single-outlet story

Views 4 Community interest

Brief read Under 1 min brief 27 words

Summary

(MedPage Today) -- A U.S. judge rejected Novo Nordisk's request to temporarily block Eli Lilly from running advertisements claiming its weight-loss and diabetes drugs are more powerful.

Read original at MedPage Today

Medical Xpress28m ago1 view
IDSA: Earlier introduction of HPV vaccine improves initiation, completion by age 13Continue reading
NPR35m ago1 view
The Ebola outbreak is breaking records -- and just marked a grim milestoneContinue reading
Medical Xpress48m ago4 views
Pathology research identifies potential new target for preventing brain metastasisContinue reading
MedPage Today53m ago1 view
Novel HDAC Inhibitor Hits Main Goal in Unresectable Melanoma TrialContinue reading

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page

HAPPENING NOW

Bid to Block GLP-1 Ads Denied; First Weekly Insulin for T2D in Kids; Fertility Fell

More from Health